383.84
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$380.53
Offen:
$379.92
24-Stunden-Volumen:
3.19M
Relative Volume:
1.84
Marktkapitalisierung:
$86.72B
Einnahmen:
$183.12B
Nettoeinkommen (Verlust:
$5.92B
KGV:
14.98
EPS:
25.63
Netto-Cashflow:
$3.67B
1W Leistung:
+3.11%
1M Leistung:
-7.21%
6M Leistung:
-5.68%
1J Leistung:
-24.34%
Elevance Health Inc Stock (ELV) Company Profile
Firmenname
Elevance Health Inc
Sektor
Branche
Telefon
(800) 331-1476
Adresse
220 VIRGINIA AVENUE, INDIANAPOLIS
Vergleichen Sie ELV mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ELV
Elevance Health Inc
|
383.84 | 84.11B | 183.12B | 5.92B | 3.67B | 25.63 |
![]()
UNH
Unitedhealth Group Inc
|
301.91 | 268.12B | 410.06B | 22.11B | 24.86B | 23.88 |
![]()
CI
Cigna Group
|
316.64 | 84.41B | 254.47B | 5.03B | 6.01B | 18.06 |
![]()
CVS
Cvs Health Corp
|
64.04 | 76.95B | 378.96B | 5.28B | 5.94B | 4.19 |
![]()
HUM
Humana Inc
|
233.13 | 27.15B | 117.76B | 1.21B | 2.39B | 9.95 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2025-03-17 | Hochstufung | Argus | Hold → Buy |
2025-01-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
2024-10-18 | Herabstufung | Argus | Buy → Hold |
2024-07-18 | Herabstufung | BofA Securities | Buy → Neutral |
2024-06-24 | Eingeleitet | Morgan Stanley | Overweight |
2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
2024-03-06 | Eingeleitet | Barclays | Overweight |
2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2023-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
2023-03-28 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2022-09-09 | Hochstufung | BofA Securities | Neutral → Buy |
2022-08-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
Alle ansehen
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV - TradingView
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesELV - PR Newswire
Not Many Are Piling Into Elevance Health, Inc. (NYSE:ELV) Just Yet - simplywall.st
Insiders At Elevance Health Sold US$6.9m In Stock, Alluding To Potential Weakness - Yahoo Finance
ELV CLASS NOTICE: Elevance Health, Inc. Investors may have - GlobeNewswire
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit - marketscreener.com
DEADLINE ALERT for WST, DMRC, CODI, ELV: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - GlobeNewswire Inc.
Cantor Fitzgerald Reiterates ‘Overweight’ Rating on Elevance Health (ELV) - Insider Monkey
ELV Investors Have the Opportunity to Lead the Elevance Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - PR Newswire
ELV REMINDER: BFA Law Reminds Elevance Health, Inc. - GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elevance - GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV - TradingView
Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Elevance Health: A Bargain At 11x Earnings (NYSE:ELV) - Seeking Alpha
Elevance sues providers, HaloMD over No Surprises Act allegations - Modern Healthcare
ELV Investors Have the Opportunity to Lead the Elevance Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire
Elevance Looks Cheap Now: But is it Time to Buy or Dodge? - Yahoo Finance
Why Elevance Health Shares Are Surging Premarket On Wednesday? - Benzinga
Elevance Health Reaffirms 2025 Earnings Guidance Of $28.30-$29.00 Per ShareSEC Filing - marketscreener.com
Elevance Health (ELV) Reaffirms 2025 Earnings Guidance Amid Inve - GuruFocus
Elevance Health Reaffirms 2025 Earnings Guidance - TipRanks
Elevance Health maintains 2025 earnings guidance - Investing.com
ELV Class Action Lawsuit – Shareholders Should Contact - GlobeNewswire
ELV Class Action Lawsuit – Shareholders Should Contact Robbins LLP for Information About Leading the Class Action Against Elevance Health, Inc. - TradingView
ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Investors who lost money with shares of Elevance Health, Inc. - openPR.com
ELV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elevance Health, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Deadline Alert: Elevance Health, Inc. (ELV) Investors Who - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - StreetInsider
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Elevance - GlobeNewswire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV - TradingView
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure ... - Bluefield Daily Telegraph
ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance - StreetInsider
ELV FRAUD: Suffer Losses on Elevance Health, Inc.? You may - GlobeNewswire
ELV FRAUD NOTICE: Elevance Health, Inc. Investors with Losses are Reminded to Contact BFA Law about the Pending Securities Fraud Class Action - Newsfile
Elevance Health, Inc. (NYSE:ELV) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Elevance Health Inc. stock underperforms Friday when compared to competitors - MarketWatch
Elevance Worker Wants Wage Suit Sent Back To Conn. Court - Law360
UnitedHealth vs. Elevance: Which Healthcare Stock Has More Upside? - The Globe and Mail
Elevance Health Is Latest Employer Sued Over 401(k) Forfeitures - Bloomberg Law News
ELV FRAUD ALERT: Lose Money when Elevance Health, Inc. - GlobeNewswire
Robbins LLP Reminds Elevance Health, Inc. Stockholders of the Class Action Against ELV – ... - Bluefield Daily Telegraph
Robbins LLP Reminds Elevance Health, Inc. Stockholders of the Class Action Against ELV – Contact Us for Information - GlobeNewswire
Anthem Blue Cross and Blue Shield and Capital Women’s Care Announce Multi-Year Contract - Business Wire
ELV COURT NOTICE: A Securities Fraud Class Action has been Initiated against Elevance Health, Inc.Contact BFA Law if You Lost Money - ACCESS Newswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure ... - Eagle-Tribune
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance - GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV - TradingView
Elevance Health (ELV) Down 6.3% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Finanzdaten der Elevance Health Inc-Aktie (ELV)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):